| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Eye Disease | |||||
| Inflammation | |||||
| Uveitis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Eye Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Pathologic Processes | |||||
| Uveal Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Cyclosporin A Implant | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Cyclosporine | |||||
| Cyclosporins | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Infective Agents | |||||
| Antifungal Agents | |||||
| Antirheumatic Agents | |||||
| Dermatologic Agents | |||||
| Enzyme Inhibitors | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| National Eye Institute (NEI) | |||||
|
